Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Van Dijck, P, Sjollema, J, Cammue, BP, Lagrou, K, Berman, J, d'Enfert, C, Andes, DR, Arendrup, MC, Brakhage, AA, Calderone, R, Cantón, E, Coenye, T, Cos, P, Cowen, LE, Edgerton, M, Espinel-Ingroff, A, Filler, SG, Ghannoum, M, Gow, NAR, Haas, H, Jabra-Rizk, MA, Johnson, EM, Lockhart, SR, Lopez-Ribot, JL, Maertens, J, Munro, CA, Nett, JE, Nobile, CJ, Pfaller, MA, Ramage, G, Sanglard, D, Sanguinetti, M, Spriet, I, Verweij, PE, Warris, A, Wauters, J, Yeaman, MR, Zaat, SAJ & Thevissen, K 2018, 'Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms' Microbial Cell Factories, vol. 5, no. 7, pp. 300-326. https://doi.org/10.15698/mic2018.07.638

APA

CBE

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K. 2018. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. Microbial Cell Factories. 5(7):300-326. https://doi.org/10.15698/mic2018.07.638

MLA

Vancouver

Author

Van Dijck, Patrick ; Sjollema, Jelmer ; Cammue, Bruno P ; Lagrou, Katrien ; Berman, Judith ; d'Enfert, Christophe ; Andes, David R ; Arendrup, Maiken C ; Brakhage, Axel A ; Calderone, Richard ; Cantón, Emilia ; Coenye, Tom ; Cos, Paul ; Cowen, Leah E ; Edgerton, Mira ; Espinel-Ingroff, Ana ; Filler, Scott G ; Ghannoum, Mahmoud ; Gow, Neil A R ; Haas, Hubertus ; Jabra-Rizk, Mary Ann ; Johnson, Elizabeth M ; Lockhart, Shawn R ; Lopez-Ribot, Jose L ; Maertens, Johan ; Munro, Carol A ; Nett, Jeniel E ; Nobile, Clarissa J ; Pfaller, Michael A ; Ramage, Gordon ; Sanglard, Dominique ; Sanguinetti, Maurizio ; Spriet, Isabel ; Verweij, Paul E ; Warris, Adilia ; Wauters, Joost ; Yeaman, Michael R ; Zaat, Sebastian A J ; Thevissen, Karin. / Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. In: Microbial Cell Factories. 2018 ; Vol. 5, No. 7. pp. 300-326.

Bibtex

@article{19dee068e38142da91fa7bb0d3a61302,
title = "Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms",
abstract = "Unlike superficial fungal infections of the skin and nails, which are the most common fungal diseases in humans, invasive fungal infections carry high morbidity and mortality, particularly those associated with biofilm formation on indwelling medical devices. Therapeutic management of these complex diseases is often complicated by the rise in resistance to the commonly used antifungal agents. Therefore, the availability of accurate susceptibility testing methods for determining antifungal resistance, as well as discovery of novel antifungal and antibiofilm agents, are key priorities in medical mycology research. To direct advancements in this field, here we present an overview of the methods currently available for determining (i) the susceptibility or resistance of fungal isolates or biofilms to antifungal or antibiofilm compounds and compound combinations; (ii) the in vivo efficacy of antifungal and antibiofilm compounds and compound combinations; and (iii) the in vitro and in vivo performance of anti-infective coatings and materials to prevent fungal biofilm-based infections.",
author = "{Van Dijck}, Patrick and Jelmer Sjollema and Cammue, {Bruno P} and Katrien Lagrou and Judith Berman and Christophe d'Enfert and Andes, {David R} and Arendrup, {Maiken C} and Brakhage, {Axel A} and Richard Calderone and Emilia Cant{\'o}n and Tom Coenye and Paul Cos and Cowen, {Leah E} and Mira Edgerton and Ana Espinel-Ingroff and Filler, {Scott G} and Mahmoud Ghannoum and Gow, {Neil A R} and Hubertus Haas and Jabra-Rizk, {Mary Ann} and Johnson, {Elizabeth M} and Lockhart, {Shawn R} and Lopez-Ribot, {Jose L} and Johan Maertens and Munro, {Carol A} and Nett, {Jeniel E} and Nobile, {Clarissa J} and Pfaller, {Michael A} and Gordon Ramage and Dominique Sanglard and Maurizio Sanguinetti and Isabel Spriet and Verweij, {Paul E} and Adilia Warris and Joost Wauters and Yeaman, {Michael R} and Zaat, {Sebastian A J} and Karin Thevissen",
year = "2018",
month = "6",
day = "14",
doi = "10.15698/mic2018.07.638",
language = "English",
volume = "5",
pages = "300--326",
journal = "Microbial Cell Factories",
issn = "1475-2859",
publisher = "BioMed Central Ltd",
number = "7",

}

RIS

TY - JOUR

T1 - Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms

AU - Van Dijck, Patrick

AU - Sjollema, Jelmer

AU - Cammue, Bruno P

AU - Lagrou, Katrien

AU - Berman, Judith

AU - d'Enfert, Christophe

AU - Andes, David R

AU - Arendrup, Maiken C

AU - Brakhage, Axel A

AU - Calderone, Richard

AU - Cantón, Emilia

AU - Coenye, Tom

AU - Cos, Paul

AU - Cowen, Leah E

AU - Edgerton, Mira

AU - Espinel-Ingroff, Ana

AU - Filler, Scott G

AU - Ghannoum, Mahmoud

AU - Gow, Neil A R

AU - Haas, Hubertus

AU - Jabra-Rizk, Mary Ann

AU - Johnson, Elizabeth M

AU - Lockhart, Shawn R

AU - Lopez-Ribot, Jose L

AU - Maertens, Johan

AU - Munro, Carol A

AU - Nett, Jeniel E

AU - Nobile, Clarissa J

AU - Pfaller, Michael A

AU - Ramage, Gordon

AU - Sanglard, Dominique

AU - Sanguinetti, Maurizio

AU - Spriet, Isabel

AU - Verweij, Paul E

AU - Warris, Adilia

AU - Wauters, Joost

AU - Yeaman, Michael R

AU - Zaat, Sebastian A J

AU - Thevissen, Karin

PY - 2018/6/14

Y1 - 2018/6/14

N2 - Unlike superficial fungal infections of the skin and nails, which are the most common fungal diseases in humans, invasive fungal infections carry high morbidity and mortality, particularly those associated with biofilm formation on indwelling medical devices. Therapeutic management of these complex diseases is often complicated by the rise in resistance to the commonly used antifungal agents. Therefore, the availability of accurate susceptibility testing methods for determining antifungal resistance, as well as discovery of novel antifungal and antibiofilm agents, are key priorities in medical mycology research. To direct advancements in this field, here we present an overview of the methods currently available for determining (i) the susceptibility or resistance of fungal isolates or biofilms to antifungal or antibiofilm compounds and compound combinations; (ii) the in vivo efficacy of antifungal and antibiofilm compounds and compound combinations; and (iii) the in vitro and in vivo performance of anti-infective coatings and materials to prevent fungal biofilm-based infections.

AB - Unlike superficial fungal infections of the skin and nails, which are the most common fungal diseases in humans, invasive fungal infections carry high morbidity and mortality, particularly those associated with biofilm formation on indwelling medical devices. Therapeutic management of these complex diseases is often complicated by the rise in resistance to the commonly used antifungal agents. Therefore, the availability of accurate susceptibility testing methods for determining antifungal resistance, as well as discovery of novel antifungal and antibiofilm agents, are key priorities in medical mycology research. To direct advancements in this field, here we present an overview of the methods currently available for determining (i) the susceptibility or resistance of fungal isolates or biofilms to antifungal or antibiofilm compounds and compound combinations; (ii) the in vivo efficacy of antifungal and antibiofilm compounds and compound combinations; and (iii) the in vitro and in vivo performance of anti-infective coatings and materials to prevent fungal biofilm-based infections.

U2 - 10.15698/mic2018.07.638

DO - 10.15698/mic2018.07.638

M3 - Review

VL - 5

SP - 300

EP - 326

JO - Microbial Cell Factories

JF - Microbial Cell Factories

SN - 1475-2859

IS - 7

ER -

ID: 56271608